Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
influenza vaccine production
Manufacturing
GSK, Sanofi, CSL nab BARDA funding for bird flu shots
CSL Seqirus, Sanofi and GSK have collectively secured $72 million in BARDA funding to boost U.S. supply of bird flu vaccines.
Angus Liu
Oct 4, 2024 1:35pm
GSK has a busy flu shot season ahead in Canada and the US
Jul 18, 2022 9:03am
Seqirus completes $156M expansion at fill-finish plant
Jun 9, 2022 9:35am
Seqirus achieves mass-production cell-based influenza vaccines
Jun 21, 2017 2:44pm
